The U.S. Food and Drug Administration (FDA) gave Google permission earlier this month to use heart rhythm detection notification on its Fitbit wearable devices. The feature is now being rolled out, and we know which devices can use it.
Fitbit devices may now detect a person’s blood volume and heart rhythm. Wearables can screen for anomalies and indications of atrial fibrillation, which increases the risk of heart failure, dementia, and stroke. Fitbit’s own 2020 study found that its algorithms could diagnose atrial fibrillation 98% of the time, based on 455,699 users over five months.
Over 20 nations now have Fitbit Irregular Heart Rhythm Notifications. The instrument detects atrial fibrillation (AFib), which can cause heart problems. After FDA permission, the feature launched in the US this year on numerous smartwatch models.
More nations are getting Fitbit Irregular Heart Rhythm Notifications. The technique detects atrial fibrillation (AFib), which affects 3.35 million individuals worldwide and can cause heart problems. Many arrhythmia sufferers have no symptoms, making detection difficult.
The tool is currently available in over 20 countries, including the UK, Canada, and Netherlands. Fitbit Sense 2, Versa 4, and Charge 5 are 21% off at Amazon in the US.
Fitbit’s Sense, Sense 2, Versa Lite, Versa 2, Versa 3, Versa 4, Charge 3, Charge 4, Charge 5, Lux, Inspire 2, and Inspire 3 enable abnormal heart rhythm notifications. In your market, you’ll discover a wearable with this feature.
List of available markets Countries
- American Samoa
- Hong Kong
- Puerto Rico
- United States
- US Virgin Islands
- United Kingdom
The Fitbit app’s Assessments section analyses heart rhythm while sleeping for Afib. This irregular heartbeat syndrome increases the risk of blood clots, heart attacks, and stroke.